chr12-49040100-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003482.4(KMT2D):​c.7670C>T​(p.Pro2557Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00761 in 1,613,868 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2557P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 91 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

5
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 3.75

Publications

18 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005523622).
BP6
Variant 12-49040100-G-A is Benign according to our data. Variant chr12-49040100-G-A is described in ClinVar as Benign. ClinVar VariationId is 94250.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0103 (1569/152320) while in subpopulation SAS AF = 0.017 (82/4834). AF 95% confidence interval is 0.0155. There are 14 homozygotes in GnomAd4. There are 786 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1569 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
NM_003482.4
MANE Select
c.7670C>Tp.Pro2557Leu
missense
Exon 32 of 55NP_003473.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
ENST00000301067.12
TSL:5 MANE Select
c.7670C>Tp.Pro2557Leu
missense
Exon 32 of 55ENSP00000301067.7
KMT2D
ENST00000683543.2
c.7670C>Tp.Pro2557Leu
missense
Exon 32 of 56ENSP00000506726.1
KMT2D
ENST00000685166.1
c.7679C>Tp.Pro2560Leu
missense
Exon 31 of 54ENSP00000509386.1

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1575
AN:
152202
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0166
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0169
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0172
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.00614
Gnomad OTH
AF:
0.0163
GnomAD2 exomes
AF:
0.00824
AC:
2043
AN:
248030
AF XY:
0.00890
show subpopulations
Gnomad AFR exome
AF:
0.0159
Gnomad AMR exome
AF:
0.00735
Gnomad ASJ exome
AF:
0.0168
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00117
Gnomad NFE exome
AF:
0.00674
Gnomad OTH exome
AF:
0.0105
GnomAD4 exome
AF:
0.00733
AC:
10709
AN:
1461548
Hom.:
91
Cov.:
32
AF XY:
0.00775
AC XY:
5632
AN XY:
727044
show subpopulations
African (AFR)
AF:
0.0158
AC:
529
AN:
33476
American (AMR)
AF:
0.00769
AC:
344
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0155
AC:
406
AN:
26130
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39696
South Asian (SAS)
AF:
0.0178
AC:
1538
AN:
86240
European-Finnish (FIN)
AF:
0.00127
AC:
68
AN:
53352
Middle Eastern (MID)
AF:
0.0392
AC:
226
AN:
5768
European-Non Finnish (NFE)
AF:
0.00619
AC:
6882
AN:
1111814
Other (OTH)
AF:
0.0117
AC:
708
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
723
1446
2168
2891
3614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1569
AN:
152320
Hom.:
14
Cov.:
33
AF XY:
0.0106
AC XY:
786
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0165
AC:
685
AN:
41574
American (AMR)
AF:
0.0169
AC:
258
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
62
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5180
South Asian (SAS)
AF:
0.0170
AC:
82
AN:
4834
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10618
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.00615
AC:
418
AN:
68022
Other (OTH)
AF:
0.0161
AC:
34
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
79
159
238
318
397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00773
Hom.:
15
Bravo
AF:
0.0105
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.0140
AC:
54
ESP6500EA
AF:
0.00702
AC:
58
ExAC
AF:
0.00834
AC:
1008
Asia WGS
AF:
0.0120
AC:
40
AN:
3478
EpiCase
AF:
0.00851
EpiControl
AF:
0.00979

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6Other:1
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 21, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 22, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Jun 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:4
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Oct 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 14, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Kabuki syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Benign
0.88
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.030
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0055
T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
0.55
N
PhyloP100
3.8
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-3.1
D
REVEL
Uncertain
0.32
Sift
Uncertain
0.0020
D
Polyphen
0.0020
B
Vest4
0.38
MVP
0.18
MPC
0.65
ClinPred
0.021
T
GERP RS
4.4
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.12
gMVP
0.13
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189888707; hg19: chr12-49433883; COSMIC: COSV56411192; COSMIC: COSV56411192; API